Promising treatment options of triple negative breast cancer

dc.contributor.authorDvořák Josefcs
dc.contributor.authorKordíková D.cs
dc.contributor.authorLajbl-Večeřová Katarínacs
dc.contributor.authorRichter Igorcs
dc.contributor.authorHornová Janacs
dc.contributor.authorRozsypalová Anetacs
dc.contributor.authorSpisarová Evacs
dc.contributor.authorBoublíková Ludmilacs
dc.contributor.authorAbrahámová Jitkacs
dc.date.accessioned2018-09-25T12:18:18Z
dc.date.available2018-09-25T12:18:18Z
dc.date.issued2017cs
dc.format.extent4cs
dc.identifier.issn1802-4475cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/31793
dc.language.isoczecs
dc.publisherSolencs
dc.publisher.cityOlomouccs
dc.relation.ispartofseries0cs
dc.subjecttriple negative breast carcinomacs
dc.subjectplatinum derivatescs
dc.subjectolaparibcs
dc.subjectbevacizumabcs
dc.subjecteribulincs
dc.subjectpembrolizumabcs
dc.titlePromising treatment options of triple negative breast canceren
dc.titlePerspektivní léčebné postupy u triple negativního karcinomu prsucs
local.citation.epage192-195cs
local.citation.spage192-195cs
local.identifier.publikace5262
local.relation.issue11cs
Files
Collections